Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.

Csk (C-terminal Src kinase), a protein tyrosine kinase, consisting of the Src homology 2 and 3 (SH2 and SH3) domains and a catalytic domain, phosphorylates the C-terminal tail of Src-family members, resulting in downregulation of the Src family kinase activity. The Src family kinases share 37 % homology with Csk but, unlike Src-family kinases, the catalytic domain of Csk alone is weakly active and can be stimulated in trans by interacting with the Csk-SH3 domain, suggesting a mode of intradomain regulation different from that of Src family kinases. The structural determinants of this intermolecular interaction were studied by nuclear magnetic resonance (NMR) and site-directed mutagenesis techniques. Chemical shift perturbation of backbone nuclei (H' and (15)N) has been used to map the Csk catalytic domain binding site on the Csk-SH3. The experimentally determined interaction surface includes three structural elements: the N-terminal tail, a small part of the RT-loop, and the C-terminal SH3-SH2 linker. Site-directed mutagenesis revealed that mutations in the SH3-SH2 linker of the wild-type Csk decrease Csk kinase activity up to fivefold, whereas mutations in the RT-loop left Csk kinase activity largely unaffected. We conclude that the SH3-SH2 linker plays a major role in the activation of the Csk catalytic domain.

[1]  H. Hanafusa,et al.  Possible v-Crk-induced Transformation through Activation of Src Kinases (*) , 1995, The Journal of Biological Chemistry.

[2]  T. Borchert,et al.  The crystal structure of human CskSH3: structural diversity near the RT‐Src and n‐Src loop , 1994, FEBS letters.

[3]  P. Cole,et al.  Domain interactions in protein tyrosine kinase Csk. , 1999 .

[4]  S. Harrison,et al.  Crystal structures of c-Src reveal features of its autoinhibitory mechanism. , 1999, Molecular cell.

[5]  B. Howell,et al.  Csk suppression of Src involves movement of Csk to sites of Src activity , 1994, Molecular and cellular biology.

[6]  H. Hanafusa,et al.  Activation of c-Src in cells bearing v-Crk and its suppression by Csk , 1992, Molecular and cellular biology.

[7]  David Cowburn,et al.  The structure of the IgE Cɛ2 domain and its role in stabilizing the complex with its high-affinity receptor FcɛRIα , 2001, Nature Structural Biology.

[8]  J. Kuriyan,et al.  Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. , 1999, Molecular cell.

[9]  Michael J. Eck,et al.  Three-dimensional structure of the tyrosine kinase c-Src , 1997, Nature.

[10]  P. Cole,et al.  Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism. , 1998, Biochemistry.

[11]  Robert Powers,et al.  A common sense approach to peak picking in two-, three-, and four-dimensional spectra using automatic computer analysis of contour diagrams , 1991 .

[12]  C. Rudd,et al.  The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Superti-Furga,et al.  Leucine 255 of Src couples intramolecular interactions to inhibition of catalysis , 1999, Nature Structural Biology.

[14]  N. Mottet,et al.  The COOH-terminal Src kinase Csk is a tumor antigen in human carcinoma. , 2001, Cancer research.

[15]  G. Sun,et al.  Mutations in the N-terminal regulatory region reduce the catalytic activity of Csk, but do not affect its recognition of Src. , 1999, Archives of biochemistry and biophysics.

[16]  John Kuriyan,et al.  Crystal structure of the Src family tyrosine kinase Hck , 1997, Nature.

[17]  Alexander Shekhtman,et al.  A novel, specific interaction involving the Csk SH3 domain and its natural ligand , 2001, Nature Structural Biology.

[18]  Philippe Soriano,et al.  Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice , 1993, Cell.

[19]  M. Mann,et al.  The purification and characterization of the catalytic domain of Src expressed in Schizosaccharomyces pombe. Comparison of unphosphorylated and tyrosine phosphorylated species. , 1996, European journal of biochemistry.

[20]  Hiroto Yamaguchi,et al.  Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation , 1996, Nature.

[21]  Sheila M. Thomas,et al.  Specific and redundant roles of Src and Fyn in organizing the cytoskeleton , 1995, Nature.

[22]  J. Cloutier,et al.  Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. , 1996, The EMBO journal.

[23]  Toshifumi Takao,et al.  Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases , 2000, Nature.

[24]  Ad Bax,et al.  Correlating Backbone Amide and Side-Chain Resonances in Larger Proteins By Multiple Relayed Triple Resonance NMR , 1992 .

[25]  T. Yamamoto,et al.  CSK: a protein-tyrosine kinase involved in regulation of src family kinases. , 1991, The Journal of biological chemistry.

[26]  Y. Takayama,et al.  Transmembrane Phosphoprotein Cbp Positively Regulates the Activity of the Carboxyl-terminal Src Kinase, Csk* , 2000, The Journal of Biological Chemistry.

[27]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[28]  Karel Drbal,et al.  Phosphoprotein Associated with Glycosphingolipid-Enriched Microdomains (Pag), a Novel Ubiquitously Expressed Transmembrane Adaptor Protein, Binds the Protein Tyrosine Kinase Csk and Is Involved in Regulation of T Cell Activation , 2000, The Journal of experimental medicine.

[29]  M. Fournel,et al.  Negative regulation of T-cell receptor signalling by tyrosine protein kinase p50csk , 1993, Nature.

[30]  S. Curley,et al.  Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. , 1993, The Journal of clinical investigation.

[31]  M. Lamers,et al.  Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine. , 1999, Journal of molecular biology.

[32]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[33]  G. Superti-Furga,et al.  Structural requirements for the efficient regulation of the Src protein tyrosine kinase by Csk. , 1995, Oncogene.

[34]  A. Bräuninger,et al.  Isolation and characterization of a human gene that encodes a new subclass of protein tyrosine kinases. , 1992, Gene.

[35]  J. Cloutier,et al.  Requirement of the SH3 and SH2 domains for the inhibitory function of tyrosine protein kinase p50csk in T lymphocytes , 1995, Molecular and cellular biology.

[36]  H. Hanafusa,et al.  Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Resh,et al.  Palmitoylation of p59fyn is reversible and sufficient for plasma membrane association. , 1997, Molecular biology of the cell.

[38]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.